DeepMed Research

Tianjin Medical University General Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.tjmugh.com.cn

Clinical Trials

Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals

Early Phase 1

Conditions: Schizophrenia
Major Depressive Disorder
Anxiety Disorders

Interventions: Drug: Risperidone
Drug: Olanzapine
Drug: Aripiprazole

First Posted Date: 2018-12-31

Last Posted Date: 2018-12-31

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 2700

Registration Number: NCT03790085

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, China

Efficacy of FLAG Regimen for the Treatment of Patients With AML

Conditions: Leukemia, Myeloid
Leukemia
Leukemia, Myeloid, Acute

First Posted Date: 2018-07-26

Last Posted Date: 2020-04-24

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 60

Registration Number: NCT03600558

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders

Phase 2

Completed

Conditions: Neuromyelitis Optica
Neuromyelitis Optica Spectrum Disorders

Interventions: Drug: Tocilizumab Injection
Drug: Azathioprine

First Posted Date: 2017-11-22

Last Posted Date: 2019-10-24

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 118

Registration Number: NCT03350633

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia

Not Applicable

Completed

Conditions: Pain
Anesthesia

Interventions: Drug: Normal saline
Drug: Remifentanil
Drug: Dexmedetomidine injection
Drug: Sufentanil
Drug: Nalmefene

First Posted Date: 2017-03-30

Last Posted Date: 2021-08-03

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 150

Registration Number: NCT03096730

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Remote Ischemic Preconditioning for Subcortical Vascular Dementia

Not Applicable

Conditions: Subcortical Vascular Dementia

Interventions: Device: Doctormate® (60mmHg)
Device: Doctormate® (200mmHg)

First Posted Date: 2017-01-16

Last Posted Date: 2017-01-16

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 52

Registration Number: NCT03022149

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder

Phase 2

Completed

Conditions: Neuromyelitis Optica Spectrum Disorder

Interventions: Drug: Bortezomib

First Posted Date: 2016-09-08

Last Posted Date: 2024-04-11

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 5

Registration Number: NCT02893111

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Vinpocetine Inhibits NF-κB-dependent Inflammation in Acute Ischemic Stroke Patients

Phase 2

Completed

Conditions: Inflammation
Vinpocetine
Stroke
Immunoregulation

Interventions: Drug: Aspirin
Drug: vinpocetine

First Posted Date: 2016-08-25

Last Posted Date: 2016-08-25

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 60

Registration Number: NCT02878772

Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Phase 2

Conditions: Anemia, Aplastic

Interventions: Drug: placebo
Drug: rhTPO

First Posted Date: 2016-08-05

Last Posted Date: 2016-08-05

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 250

Registration Number: NCT02857530

Locations: 🇨🇳
Zonghong Shao, Tianjin, Tianjin, China

Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane

Not Applicable

Completed

Conditions: Neuromuscular Monitoring

Interventions: Drug: MAC 0.75
Drug: MAC 1.0
Drug: MAC 0.5
Drug: Propofol
Drug: Etomidate
Drug: Rocuronium

First Posted Date: 2016-03-17

Last Posted Date: 2016-03-17

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 175

Registration Number: NCT02711917

Multi-center Imaging Genetics Studies in China

Conditions: Schizophrenia
Major Depressive Disorders
Alzheimer Disease

First Posted Date: 2016-02-12

Last Posted Date: 2019-04-10

Lead Sponsor: Tianjin Medical University General Hospital

Target Recruit Count: 10000

Registration Number: NCT02681822

Locations: 🇨🇳
Tianjin Medical University General Hospital, Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy